Cargando…
Influence of treatment access on survival of metastatic renal cell carcinoma in brazilian cancer center
BACKGROUND: Tyrosine kinase inhibitors (TKI) and immunotherapy improved survival in metastatic renal cell carcinoma (mRCC). Disparities in treatment access are present in healthcare systems globally. The aim of this study was to analyze survival outcomes of mRCC patients treated with first-line TKIs...
Autores principales: | Leite, Luciana de M., Bergerot, Paulo G., Dettino, Aldo L. A., Augusto R., José, Zequi, Stenio de C., Formiga, Maria Nirvana da C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993945/ https://www.ncbi.nlm.nih.gov/pubmed/33621005 http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.0443 |
Ejemplares similares
-
Complete metastasectomy in renal cell carcinoma: a propensity-score matched by the International Metastatic RCC Database Consortium prognostic model
por: Fares, Aline F, et al.
Publicado: (2019) -
Assessment of Treatment Patterns for Metastatic Renal Cell Carcinoma
in Brazil
por: Bergerot, Paulo G., et al.
Publicado: (2017) -
Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic
por: Zequi, Stênio de Cássio, et al.
Publicado: (2020) -
The creation, development and diffusion of the LARCG- latin american renal cancer group
por: Zequi, Stênio de Cássio, et al.
Publicado: (2017) -
Characteristics and survival of older patients with metastatic pancreatic cancer: a retrospective analysis of the AC Camargo Cancer Center experience
por: Costa, Josenon Gomes, et al.
Publicado: (2019)